Pfizer Inc

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

PFE

Financials

Pfizer Inc

Noticias

Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings

MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer

Earnings Preview: What to Expect From Pfizer’s Report

Pfizer (PFE) Outperforms Broader Market: What You Need to Know

My Top 4 Pharma Picks Under Rising Geopolitical Risk

Dividend Harvesting Portfolio Week 267: $26,700 Allocated $2,927.54 In Projected Dividends

Guggenheim reitera recomendación de compra sobre Pfizer antes de resultados

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?

Battle of Big Pharma: Is AbbVie Stock Pulling Ahead of Pfizer?

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

My 2 Favorite Mispriced Dividends For Recurring Income